Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    November 2018
  1. MEINTJES G, Stek C, Blumenthal L, Thienemann F, et al
    Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    N Engl J Med. 2018;379:1915-1925.
    PubMed     Text format     Abstract available


  2. BLANK S, Daskalakis DC
    Neisseria gonorrhoeae - Rising Infection Rates, Dwindling Treatment Options.
    N Engl J Med. 2018;379:1795-1797.
    PubMed     Text format    


    October 2018
  3. MUFTUOGLU M, Olson A, Marin D, Ahmed S, et al
    Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy.
    N Engl J Med. 2018;379:1443-1451.
    PubMed     Text format     Abstract available


    September 2018
  4. VAN DER MEEREN O, Hatherill M, Nduba V, Wilkinson RJ, et al
    Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
    N Engl J Med. 2018 Sep 25. doi: 10.1056/NEJMoa1803484.
    PubMed     Text format     Abstract available


  5. GOLDSTEIN RH, Streed CG Jr, Cahill SR
    Being PrEPared - Preexposure Prophylaxis and HIV Disparities.
    N Engl J Med. 2018 Sep 19. doi: 10.1056/NEJMp1804306.
    PubMed     Text format    


  6. ZASH R, Makhema J, Shapiro RL
    Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.
    N Engl J Med. 2018;379:979-981.
    PubMed     Text format    


    August 2018
  7. EMU B, Fessel J, Schrader S, Kumar P, et al
    Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
    N Engl J Med. 2018;379:645-654.
    PubMed     Text format     Abstract available


  8. SHEIKH V, Murray JS, Sherwat A
    Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty.
    N Engl J Med. 2018;379:605-607.
    PubMed     Text format    


  9. SHAH NN, Singavi AK, Harrington A
    Daratumumab in Primary Effusion Lymphoma.
    N Engl J Med. 2018;379:689-690.
    PubMed     Text format    


    July 2018
  10. HONIGBERG MC, Westlake AA, Griffin GK, Vaidya A, et al
    A Lump in the Neck.
    N Engl J Med. 2018;379:e8.
    PubMed     Text format    


  11. RECIO R, Perez-Ayala A
    Cryptococcus neoformans Meningoencephalitis.
    N Engl J Med. 2018;379:281.
    PubMed     Text format    


  12. NEMES E, Geldenhuys H, Rozot V, Rutkowski KT, et al
    Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    N Engl J Med. 2018;379:138-149.
    PubMed     Text format     Abstract available


    June 2018

  13. Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMx180021.
    PubMed     Text format    


  14. MULASI I
    The Scarlet Virus.
    N Engl J Med. 2018;378:2157-2159.
    PubMed     Text format    


    May 2018
  15. ZUCMAN D, Mellot F, Couderc L
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144-5.
    PubMed     Text format    


  16. CHAMSEDDINE AN, Loulergue P, Mir O
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144.
    PubMed     Text format    



  17. HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:2144-2145.
    PubMed     Text format    


  18. JUSTMAN JE, Mugurungi O, El-Sadr WM
    HIV Population Surveys - Bringing Precision to the Global Response.
    N Engl J Med. 2018;378:1859-1861.
    PubMed     Text format    


  19. FARIA D, Freitas A
    Tuberculous Pericarditis.
    N Engl J Med. 2018;378:e27.
    PubMed     Text format    


  20. ZUGER A
    Moving On.
    N Engl J Med. 2018;378:1763-1765.
    PubMed     Text format    


  21. GOMEZ CA, Banaei N
    Trypanosoma cruzi Reactivation in the Brain.
    N Engl J Med. 2018;378:1824.
    PubMed     Text format    


    April 2018
  22. BACK DJ
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1654-5.
    PubMed     Text format    


  23. SANDRONI S
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1654.
    PubMed     Text format    


  24. ROUGH K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, et al
    Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    N Engl J Med. 2018;378:1593-1603.
    PubMed     Text format     Abstract available



  25. Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2018;378:1655-6.
    PubMed     Text format    


  26. FELDMANN H
    Virus in Semen and the Risk of Sexual Transmission.
    N Engl J Med. 2018;378:1440-1441.
    PubMed     Text format    


  27. MEAD PS, Duggal NK, Hook SA, Delorey M, et al
    Zika Virus Shedding in Semen of Symptomatic Infected Men.
    N Engl J Med. 2018;378:1377-1385.
    PubMed     Text format     Abstract available


    March 2018
  28. YANG YT, Underhill K
    Rethinking Criminalization of HIV Exposure - Lessons from California's New Legislation.
    N Engl J Med. 2018;378:1174-1175.
    PubMed     Text format    


  29. ARD KL, Kelly HR, Gandhi RT, Louissaint A Jr., et al
    Case 9-2018: A 55-Year-Old Man with HIV Infection and a Mass on the Right Side of the Face.
    N Engl J Med. 2018;378:1143-1152.
    PubMed     Text format    


  30. YARCHOAN R, Uldrick TS
    HIV-Associated Cancers and Related Diseases.
    N Engl J Med. 2018;378:1029-1041.
    PubMed     Text format    


  31. MOLLOY SF, Kanyama C, Heyderman RS, Loyse A, et al
    Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
    N Engl J Med. 2018;378:1004-1017.
    PubMed     Text format     Abstract available



  32. HIV Drug Resistance.
    N Engl J Med. 2018;378:873-875.
    PubMed     Text format    


  33. GOTTLIEB GS, Raugi DN, Smith RA
    HIV Drug Resistance.
    N Engl J Med. 2018;378:874-5.
    PubMed     Text format    


  34. BERTAGNOLIO S, Jordan MR, Doherty M
    HIV Drug Resistance.
    N Engl J Med. 2018;378:874.
    PubMed     Text format    


  35. INZAULE SC, Rinke de Wit TF, Hamers RL
    HIV Drug Resistance.
    N Engl J Med. 2018;378:873-4.
    PubMed     Text format    


    January 2018
  36. MARTIN EG, Schackman BR
    Treating and Preventing HIV with Generic Drugs - Barriers in the United States.
    N Engl J Med. 2018;378:316-319.
    PubMed     Text format    


  37. FAUCI AS, Eisinger RW
    PEPFAR - 15 Years and Counting the Lives Saved.
    N Engl J Med. 2018;378:314-316.
    PubMed     Text format    


  38. MARGOLIS DM, Garcia JV
    Countering HIV - Three's the Charm?
    N Engl J Med. 2018;378:295-297.
    PubMed     Text format    


    December 2017
  39. SI Z, Qiao J
    Talaromyces marneffei Infection.
    N Engl J Med. 2017;377:2580.
    PubMed     Text format    


  40. COHEN SD, Kopp JB, Kimmel PL
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2017;377:2363-2374.
    PubMed     Text format    


    November 2017
  41. GRABOWSKI MK, Serwadda DM, Gray RH, Nakigozi G, et al
    HIV Prevention Efforts and Incidence of HIV in Uganda.
    N Engl J Med. 2017;377:2154-2166.
    PubMed     Text format     Abstract available


  42. GOMEZ-MOYANO E, Crespo-Erchiga V
    HIV Infection Manifesting as Proximal White Onychomycosis.
    N Engl J Med. 2017;377:e26.
    PubMed     Text format    


    October 2017
  43. BEYRER C, Pozniak A
    HIV Drug Resistance - An Emerging Threat to Epidemic Control.
    N Engl J Med. 2017;377:1605-1607.
    PubMed     Text format    


  44. KENNEDY SB, Bolay F, Kieh M, Grandits G, et al
    Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
    N Engl J Med. 2017;377:1438-1447.
    PubMed     Text format     Abstract available


    September 2017
  45. RICHARDSON HS, Eyal N, Campbell JI, Haberer JE, et al
    When Ancillary Care Clashes with Study Aims.
    N Engl J Med. 2017;377:1213-1215.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: